A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Clinical trial NCT02659397 · COMPLETED
Trial details
- NCT number
- NCT02659397
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-07-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.